TickerFile

Akebia Therapeutics, Inc.

AKBA

Chart

Real-time prices · TradingView

Latest report

Published Aug 12, 2026

Akebia Q2 FY2026 Earnings: Vafseo Accelerates as Auryxia Fades and the Term Loan Looms

In-depth research on AKBA covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.

3,433 words15 min read
Read report